Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“Former Rep. Gary Merchant (D - Sull 6).” Granite Record, https://graniterecord.org/legislator/gary-merchant-sull-6. Accessed 19 Oct. 2026.
APA
Granite Record. (n.d.). Former Rep. Gary Merchant (D - Sull 6). Retrieved 19 Oct. 2026, from https://graniterecord.org/legislator/gary-merchant-sull-6
Chicago
Granite Record. “Former Rep. Gary Merchant (D - Sull 6).” Accessed 19 Oct. 2026. https://graniterecord.org/legislator/gary-merchant-sull-6.
BibTeX
@misc{legislator-gary-merchant-sull-6, title = {Former Rep. Gary Merchant (D - Sull 6)}, howpublished = {Granite Record}, url = {https://graniterecord.org/legislator/gary-merchant-sull-6}, note = {Accessed 19 Oct. 2026} }

Former Representative Gary Merchant (D - Sull 6)

On record 2019 to 2024. This page is their record in the New Hampshire General Court; it is not a current directory entry.

  • Recorded roll call votes: Nay 537, Yea 794, Not Voting/Not Excused 25, Not Voting/Excused 75
  • Bills sponsored: 84, 15 as prime sponsor

Bills Sponsored

  • SB 600 (2024): (New Title) relative to the board of pharmacy and certified public accountant examinations.
  • SB 560 (2024): relative to establishing a committee to study the impact of pharmacy benefit manager operations on cost, administration, and distribution of prescription drugs.
  • SB 559-FN (2024): (New Title) relative to the New Hampshire vaccine association.
  • SB 557 (2024): relative to prohibiting discriminatory actions related to participation in the federal 340B Drug Pricing Program.
  • SB 392-FN-A (2024): relative to lead paint hazard remediation.
  • HB 518 (2024): (New Title) relative to the administration of occupations by the office of professional licensure and certification. (prime sponsor)
  • HB 383 (2024): relative to provider contract standards for pharmacy benefit managers.
  • HB 332-FN-A-LOCAL (2024): relative to school building aid for eligible projects.
  • HB 329-FN (2024): establishing an ALS (Amyotrophic Lateral Sclerosis) registry in New Hampshire.
  • HB 306 (2024): relative to prohibiting reunification therapy.
  • HB 303-FN (2024): relative to insurance coverage for pain management services.
  • HB 274 (2024): relative to the administrative rulemaking process.
  • HB 200 (2024): relative to choice of counselor to evaluate a child in family court proceedings.
  • HB 1712 (2024): renewing the committee to study non-pharmacological treatment options for patients with chronic pain.
  • HB 1678-FN (2024): establishing a New Hampshire farm to school local food incentive pilot program.
  • HB 1609-FN (2024): relative to the commission on the primary care workforce and the state office of rural health.
  • HB 1601-FN-A (2024): relative to the prescription drug affordability board. (prime sponsor)
  • HB 1461-FN (2024): relative to live-streaming all properly noticed meetings and hearings of elected and appointed municipal bodies.
  • HB 1460-FN (2024): relative to the sale of county property.
  • HB 1365 (2024): relative to substitution of biological products by pharmacies. (prime sponsor)
  • HB 1137-FN (2024): relative to trafficking offences and special restitution for human trafficking victims
  • HB 1042 (2024): (New Title) repealing the requirement that each pharmacy establish a continuous quality improvement program.
  • SB 35 (2023): relative to RSV vaccine administration.
  • SB 238-FN (2023): (New Title) relative to prescribing opioids via telehealth medicine.
  • SB 200 (2023): relative to optometrists.
  • HB 66 (2023): (New Title) establishing a committee to study non-pharmacological treatment options for patients with chronic pain. (prime sponsor)
  • HB 655-FN (2023): relative to the office of professional licensure and certification.
  • HB 487-FN (2023): establishing a New Hampshire farm-to-school reimbursement program.
  • HB 445-FN (2023): relative to the operational funds of OPLC.
  • HB 426 (2023): relative to the regulation of pharmacists-in-charge and pharmacies.
  • HB 337-FN (2023): (New Title) relative to directing the office of professional licensure and certification to provide notice of public meetings and an opportunity for comment from the public, and creating a new attorney II position. (prime sponsor)
  • HB 325 (2023): relative to the controlled drug prescription health and safety program advisory council members. (prime sponsor)
  • HB 323 (2023): relative to establishing a committee on emerging medical technologies.
  • HB 295-FN (2023): relative to requiring all selectboard and school board meetings to be recorded and broadcast live online.
  • HB 224-FN (2023): repealing the criminal and civil penalties from the fetal life protection act.
  • HB 223 (2023): relative to prescription refills.
  • HB 136 (2023): relative to the department of health and human services collaborating and holding a roll call vote on final proposal of rules with the advisory council prior to departmental rulemaking. (prime sponsor)
  • SB 450 (2022): relative to the prescription drug affordability board.
  • SB 409 (2022): relative to disaster relief loans.
  • SB 337-FN (2022): relative to emergency medical and trauma services data sharing to the purposes of analysis.
  • SB 335 (2022): relative to collaborative pharmacy practice agreements.
  • SB 289 (2022): (New Title) relative to glucagon administration and relative to the dispenser report under the controlled drug prescription health and safety program.
  • HB 576 (2022): relative to victims compensation fund eligibility.
  • HB 562 (2022): exempting victims of trafficking in persons from participating in children in need of services proceedings.
  • HB 267 (2022): relative to construction standards for schools.
  • HB 1657-FN-A (2022): establishing a New Hampshire farm to school reimbursement program.
  • HB 1566-FN (2022): relative to the New Hampshire prescription drug affordability board.
  • HB 1332 (2022): excepting public universities and colleges from requirements under medical freedom in immunizations.
  • HB 1207-FN (2022): requiring an employer to provide paid time off for an employee to vote.
  • HB 1187 (2022): relative to milk pasteurization.
  • HB 1121 (2022): relative to new solid waste sites.
  • HB 1046 (2022): relative to the election of the Sullivan county commissioners.
  • HB 1029 (2022): relative to the Claremont police commission.
  • HB 1012 (2022): relative to notice for the cutting of trees by utilities.
  • SB 45 (2021): relative to the controlled drug prescription health and safety program.
  • HB 88 (2021): relative to the city of Claremont police commission.
  • HB 79 (2021): relative to town health officers.
  • HB 75 (2021): renaming and adjusting the membership of the New Hampshire commission on deafness and hearing loss.
  • HB 572 (2021): relative to pharmacist administration of vaccines and allowing a licensed advanced pharmacy technician to administer vaccines. (prime sponsor)
  • HB 499 (2021): (New Title) relative to the use of face recognition technology.
  • HB 479 (2021): (New Title) relative to pharmacist provider status, nicotine cessation therapy, and pharmacy benefit manager requirements. (prime sponsor)
  • HB 444 (2021): relative to the board of pharmacy. (prime sponsor)
  • HB 345 (2021): establishing a license for mushroom harvesters.
  • HB 173-FN (2021): requiring the independent investment committee of the New Hampshire retirement system to report investment fees.
  • HB 143 (2021): (New Title) relative to an electronic prescription drug program and establishing licensure and requirements for licensed social workers, licensed social work associates, and social work conditional licenses. (prime sponsor)
  • SB 676-FN (2020): relative to the controlled drug prescription health and safety program.
  • HB 596-FN (2020): relative to eligibility for agricultural plates.
  • HB 1610-FN (2020): establishing the manufacturer pharmaceutical drug take-back program.
  • HB 1604 (2020): relative to agricultural registration for certain utility vehicles.
  • HB 1600-FN-A (2020): (New Title) relative to smoking cessation therapy and pharmacist reimbursement under Medicaid and making an appropriation therefor and relative to insurance coverage for pharmacist cognitive services.
  • HB 1545 (2020): relative to regulation of interpreters for the deaf, deaf blind, and hard of hearing.
  • HB 1536 (2020): relative to pharmacists-in-charge, the inspection and regulation of prescription drugs by the pharmacy board, and disciplinary actions by the pharmacy board. (prime sponsor)
  • HB 1443 (2020): relative to the city of Claremont police commission.
  • HB 1404 (2020): (New Title) relative to HIV/AIDS prophylaxis treatment for minors without parental consent.
  • HB 1332 (2020): relative to an electronic prescription drug program. (prime sponsor)
  • HB 1294 (2020): relative to the limited immunity of pharmacists.
  • HB 1280-FN (2020): (New Title) relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative to prior authorization for prescription drug coverage, and requiring insurance coverage for epinephrine auto-injectors.
  • HB 1134 (2020): renaming the New Hampshire commission on deafness and hearing loss.
  • HB 1128 (2020): adding deaf or hard of hearing to the medical conditions that may be indicated on a driver's license or nondriver's identification.
  • SB 260-FN (2019): (New Title) establishing the New Hampshire pharmaceutical assistance pilot program for seniors and making an appropriation therefor.
  • HB 676-FN-A-LOCAL (2019): repealing the collection of the state education property tax.
  • HB 615 (2019): relative to the regulation of pharmacies and pharmacists. (prime sponsor)
  • HB 463-FN (2019): (Second New Title) relative to licensure of advanced pharmacy technicians. (prime sponsor)
  • HB 370 (2019): relative to membership on city and town planning boards.

Recent Votes

  • October 10, 2024: HB194, Veto Override — Nay
  • October 10, 2024: HB274, Veto Override — Yea
  • October 10, 2024: HB396, Veto Override — Nay
  • October 10, 2024: HB1093, Veto Override — Nay
  • October 10, 2024: HB1187, Veto Override — Nay
  • October 10, 2024: HB1233, Veto Override — Nay
  • October 10, 2024: HB1293, Veto Override — Nay
  • October 10, 2024: HB1415, Veto Override — Yea
  • October 10, 2024: HB1581, Veto Override — Yea
  • October 10, 2024: HB1622, Veto Override — Yea
  • June 13, 2024: Rules Suspension — Nay
  • June 13, 2024: Print Remarks — Nay
  • June 13, 2024: HB1215, Adopt CofC Report — Nay
  • June 13, 2024: HB1265, Adopt CofC Report — Yea
  • June 13, 2024: HB1400, Adopt CofC Report — Yea
  • June 13, 2024: HB1616, Adopt CofC Report — Nay
  • June 13, 2024: HB1665, Adopt CofC Report — Nay
  • June 13, 2024: HB1633, Remove from Table — Nay
  • May 30, 2024: HB1018, Non Concur — Yea
  • May 30, 2024: HB185, Reconsider — Nay
  • May 30, 2024: HB1186, Concur — Nay
  • May 30, 2024: HB1305, Concur — Nay
  • May 30, 2024: HB1607, Concur — Nay
  • May 30, 2024: HB1215, Concur — Yea
  • May 30, 2024: HB1596, Req CofC — Nay
  • May 23, 2024: SB418, OTP — Nay
  • May 23, 2024: CACR22, Table — Yea
  • May 23, 2024: CACR22, OTP — Nay
  • May 23, 2024: SB217, ITL — Nay
  • May 23, 2024: SB311, Adopt Floor Amendment — Nay
  • May 23, 2024: SB396, Adopt Floor Amendment — Yea
  • May 23, 2024: SB403, OTP — Yea
  • May 23, 2024: SB417, Adopt Amendment — Nay
  • May 23, 2024: SB417, OTPA — Yea
  • May 23, 2024: Rules Suspension — Nay
  • May 23, 2024: SB476, Adopt Floor Amendment — Yea
  • May 23, 2024: SB476, OTPA — Yea
  • May 23, 2024: SB499, Adopt Amendment — Yea
  • May 23, 2024: SB503, Adopt Floor Amendment — Nay
  • May 23, 2024: SB505, OTP — Yea
  • May 23, 2024: SB559, Adopt Floor Amendment — Nay
  • May 23, 2024: SB431, OTPA — Yea
  • May 23, 2024: SB358, ITL — Yea
  • May 23, 2024: SB358, Reconsider — Nay
  • May 23, 2024: SB358, ITL — Yea
  • May 23, 2024: SB501, OTP — Yea
  • May 23, 2024: SB485, Adopt Floor Amendment — Nay
  • May 23, 2024: SB485, OTPA — Nay
  • May 9, 2024: SB459, OTPA — Yea
  • May 9, 2024: SB537, Table — Yea
  • May 9, 2024: SB63, Remove from Table — Nay
  • May 9, 2024: SB63, OTP — Nay
  • May 9, 2024: SB413, Adopt Amendment — Nay
  • May 9, 2024: SB576, ITL — Yea
  • May 9, 2024: SB576, Table — Yea
  • May 9, 2024: SB576, OTP — Nay
  • May 9, 2024: SB383, OTPA — Nay
  • May 9, 2024: SB383, Reconsider — Yea
  • May 9, 2024: SB574, OTPA — Yea
  • May 9, 2024: SB426, Adopt Floor Amendment — Yea
  • May 9, 2024: SB508, Adopt Amendment — Yea
  • May 2, 2024: SB417, Table — Nay
  • May 2, 2024: SB417, OTP — Yea
  • May 2, 2024: SB563, Table — Yea
  • May 2, 2024: SB219, OTP — Nay
  • May 2, 2024: SB341, Indefinitely Postpone — Yea
  • May 2, 2024: SB380, ITL — Yea
  • May 2, 2024: SB380, Indefinitely Postpone — Yea
  • May 2, 2024: SB403, OTPA — Yea
  • May 2, 2024: SB496, ITL — Yea
  • May 2, 2024: SB567, OTP — Nay
  • May 2, 2024: SB63, OTP — Nay
  • May 2, 2024: SB538, ITL — Nay
  • May 2, 2024: SB476, OTP — Yea
  • May 2, 2024: SB219, Reconsider — Yea
  • May 2, 2024: SB219, OTP — Nay
  • May 2, 2024: SB375, Interim Study — Yea
  • May 2, 2024: SB219, ITL — Yea
  • April 11, 2024: HB1178, Interim Study — Nay
  • April 11, 2024: HB1178, OTPA — Yea
  • April 11, 2024: HB1199, ITL — Nay
  • April 11, 2024: HB1199, OTP — Yea
  • April 11, 2024: HB1199, Indefinitely Postpone — Nay
  • April 11, 2024: HB1212, Table — Nay
  • April 11, 2024: HB1288, Table — Not Voting/Not Excused
  • April 11, 2024: HB1288, OTP — Nay
  • April 11, 2024: HB1394, OTPA — Yea
  • April 11, 2024: HB1577, Table — Yea
  • April 11, 2024: HB1583, Table — Nay
  • April 11, 2024: HB1595, Interim Study — Yea
  • April 11, 2024: HB1633, OTPA — Not Voting/Not Excused
  • April 11, 2024: HB1649, Adopt Floor Amendment — Nay
  • April 11, 2024: HB1649, Adopt Floor Amendment — Nay
  • April 11, 2024: HB1649, Table — Nay
  • April 11, 2024: HB1649, OTPA — Yea
  • April 11, 2024: HB1656, Adopt Amendment — Yea
  • April 11, 2024: HB1656, OTPA — Yea
  • April 11, 2024: HB1678, ITL — Nay
  • March 28, 2024: HB1539, OTP — Yea
  • March 28, 2024: HB1084, Table — Nay

And 1,331 earlier votes.

Sources